April 7 (Reuters) - Avita Medical Ltd AVH.AX :
* Asx alert-FDA approves more compassionate use cases & sites for recell-AVH.AX
* U.S. FDA approved further increase in number of patients who can be treated in U.S. With recell regenerative medical device under Avita Medical
* Expects to submit its clinical and non-clinical data package in mid-2017, with an anticipated FDA approval in the second calendar quarter of 2018 Source text for Eikon: Further company coverage: AVH.AX